SpringerLink
Log in

Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

An integrated treatment strategy using peritonectomy procedures plus hyperthermic intraperitoneal chemotherapy (HIPEC) is now a clinical standard of care in selected patients with peritoneal metastases and primary peritoneal tumors. This comprehensive approach can offer many patients, who hitherto had no hope of cure, a good quality of life and survival despite limited morbidity. The increasingly successful results and chance of interfering in the natural history of disease has prompted research to develop for some clinical conditions a therapeutic strategy designed to prevent malignant peritoneal dissemination before it becomes clinically evident and treat it microscopically (tertiary prevention). The main factor governing successful cytoreductive surgery and predicting outcome is the extent of peritoneal spread assessed with the peritoneal cancer index (PCI). In peritoneal metastases from colorectal and gastric cancer the PCI score acquires a specific role acting as the cut-off between patients who can undergo curative surgery or palliation. Long-term results show that the only group enjoying favorable results are patients with limited disease (a statistical minority). By applying to appropriately selected patients with primary malignancies a proactive management strategy including HIPEC we can treat patients with microscopic peritoneal dissemination and therefore at PCI 0. Among treated conditions pseudomyxoma peritonei enjoys the best results. But a major future advance comes from identifying among lesions at major risk of pseudomyxoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sadeghi B, Arvieux C, Glehen O, et al. (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363

    Article  CAS  PubMed  Google Scholar 

  2. Sugarbaker PH (1996) Peritoneal carcinomatosis: principle of management. Kluwer Academic, Boston

    Google Scholar 

  3. Sugarbaker PH (2013) Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas. Cine-Med Publishing Inc.

  4. Chua TC, Moran BJ, Sugarbaker PH, et al. (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 10;30(20):2449–2456

    Article  Google Scholar 

  5. Bakrin N, Bereder JM, Decullier E, et al. (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39(12):1435–1443

    Article  CAS  PubMed  Google Scholar 

  6. Yang XJ, Huang CQ, Suo T, et al. (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18(6):1575–1581

    Article  PubMed  PubMed Central  Google Scholar 

  7. Elias D, Gilly F, Boutitie F, et al. (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28(1):63–68

    Article  PubMed  Google Scholar 

  8. Yan TD, Deraco M, Baratti D, et al. (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237–6242

    Article  PubMed  Google Scholar 

  9. Sugarbaker PH (2015) Prevention and management of peritoneal metastases from gastrointestinal cancer: a short history of a paradigm for peritoneal surface malignancies. In: Di Giorgio A, Pinto E, Sammartino P, Roviello F (eds) In Treatment of peritoneal surface malignancies: state of art and perspectives, Editors edn. Springer Verlag, pp. 93–105

  10. Yan L, Yang Y, Yang L (2014) Report of the 9th international congress on peritoneal surface malignancies. Cancer Biol Med 11(4):281–284

    Google Scholar 

  11. Cardi M, Sammartino P, Framarino ML, et al. (2013) Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 cases. Breast 22(5):845–849

    Article  PubMed  Google Scholar 

  12. van Oudheusden TR, Lemmens VE, Braam HJ (2015) Peritoneal metastases from small bowel cancer: results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands. Surgery 157(6):1023–1027

    Article  PubMed  Google Scholar 

  13. Delotte J, Desantis M, Frigenza M, et al. (2014) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of endometrial cancer with peritoneal carcinomatosis. Eur J Obstet Gynecol Reprod Biol 172:111–114

    Article  PubMed  Google Scholar 

  14. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374

    Article  CAS  PubMed  Google Scholar 

  15. da Silva RG, Sugarbaker PH (2006) Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203(6):878–886

    Article  PubMed  Google Scholar 

  16. Elias D, Mariani A, Cloutier AS, et al. (2014) Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol 40(11):1467–1473

    Article  CAS  PubMed  Google Scholar 

  17. Goéré D, Souadka A, Faron M, et al. (2015) Extent of Colorectal Peritoneal Carcinomatosis: Attempt to Define a Threshold Above Which HIPEC Does Not Offer Survival Benefit: A Comparative Study. Ann Surg Oncol 29[Epub ahead of print]

  18. Canbay E, Mizumoto A, Ichinose M, et al. (2014) Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Ann Surg Oncol 21(4):1147–1152

    Article  PubMed  Google Scholar 

  19. Sugarbaker PH (2000) It's what the surgeon doesn't see that kills the patient. J Nippon Med Sch 67(1):5–8

    Article  CAS  PubMed  Google Scholar 

  20. Misdraji J (2015) Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei. Mod Pathol 28(Suppl 1):S67–S79

    Article  PubMed  Google Scholar 

  21. McDonald JR, O'Dwyer ST, Rout S, et al. (2012) Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg 99(7):987–992

    Article  CAS  PubMed  Google Scholar 

  22. Honoré C, Caruso F, Dartigues P, et al. (2015) Strategies for preventing pseudomyxoma peritonei after resection of a mucinous neoplasm of the appendix. Anticancer Res 35(9):4943–4947

    PubMed  Google Scholar 

  23. Torre LA, Bray F, Siegel RL, et al. (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

    Article  PubMed  Google Scholar 

  24. D'Angelica M, Gonen M, Brennan MF, et al. (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240(5):808–816

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sasako M, Sano T, Yamamoto S, et al. (2008) Japan clinical oncology group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359(5):453–462

    Article  CAS  PubMed  Google Scholar 

  26. Kuramoto M, Shimada S, Ikeshima S, et al. (2009) Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 250(2):242–246

    Article  PubMed  Google Scholar 

  27. Boku N (2008) Gastrointestinal oncology study group of Japan clinical oncology group. Chemotherapy for metastatic disease: review from JCOG trials. Int J Clin Oncol 13(3):196–200

    Article  CAS  PubMed  Google Scholar 

  28. Glehen O, Gilly FN, Arvieux C, et al. (2010) Association Française de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370–2377

    Article  PubMed  Google Scholar 

  29. Magge D, Zenati M, Mavanur A, et al. (2014) Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis. Ann Surg Oncol 21(5):1448–1455

    Article  PubMed  PubMed Central  Google Scholar 

  30. Badgwell B, Cormier JN, Krishnan S, et al. (2008) Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 15(10):2684–2691

    Article  PubMed  Google Scholar 

  31. Lorenzen S, Panzram B, Rosenberg R, et al. (2010) Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection. Ann Surg Oncol 17(10):2733–2739

    Article  PubMed  Google Scholar 

  32. Leake PA, Cardoso R, Seevaratnam R, et al. (2011) A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer 15(Suppl 1):S27–S37

    PubMed  Google Scholar 

  33. Huang JY, Xu YY, Sun Z, et al. (2012) Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev 13(9):4379–4385

    Article  PubMed  Google Scholar 

  34. Sun J, Song Y, Wang Z, et al. (2012) Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 12:526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Mi DH, Li Z, Yang KH, et al. (2013) Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperth 29(2):156–167

    Article  CAS  Google Scholar 

  36. Jemal A, Bray F, Mm C, et al. (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  37. http://www.cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional

  38. Pugh SA, Shinkins B, Fuller A et al (2015) Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial. Ann Surg. [Epub ahead of print].

  39. Augestad KM, Bakaki PM, Rose J, et al. (2015) Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis. Cancer Epidemiol 39(5):734–744

    Article  CAS  PubMed  Google Scholar 

  40. Gall FP, Hermanek P (1992) Change and current status of surgical treatment of colorectal cancer. Report of experiences of the Erlangen Surgical University Clinic. Chirurg 63(4):227–234

    CAS  PubMed  Google Scholar 

  41. West NP, Sutton KM, Ingeholm P, et al. (2010) Improving the quality of colon cancer surgery through a surgical education program. Dis Colon Rectum 53(12):1594–1603

    Article  PubMed  Google Scholar 

  42. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482

    Article  CAS  PubMed  Google Scholar 

  43. Martling AL, Holm T, Rutqvist LE, et al. (2000) Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm. Stockholm colorectal cancer study group, Basingstoke bowel cancer research project. Lancet 356(9224):93–96

    Article  CAS  PubMed  Google Scholar 

  44. Kapiteijn E, Putter H, van de Velde CJ (2002) Cooperative investigators of the Dutch ColoRectal cancer group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 89(9):1142–1149

    Article  CAS  PubMed  Google Scholar 

  45. Wibe A, Møller B, Norstein J, et al. (2002) Norwegian rectal cancer group. A national strategic change in treatment policy for rectal cancer–implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45(7):857–866

    Article  PubMed  Google Scholar 

  46. Birgisson H, Talbäck M, Gunnarsson U, et al. (2005) Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 31(8):845–853

    Article  CAS  PubMed  Google Scholar 

  47. Iversen LH, Nørgaard M, Jepsen P, et al. (2007) Northern Danish cancer quality assessment group. Trends in colorectal cancer survival in northern Denmark: 1985-2004. Color Dis 9(3):210–217

    Article  CAS  Google Scholar 

  48. Talbäck M, Stenbeck M, Rosén M, et al. (2003) Cancer survival in Sweden 1960-1998–developments across four decades. Acta Oncol 42(7):637–659

    Article  PubMed  Google Scholar 

  49. Lemmens V, van Steenbergen L, Janssen-Heijnen M, et al. (2010) Trends in colorectal cancer in the south of The Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol 49(6):784–796

    Article  PubMed  Google Scholar 

  50. Siegel R, Ma J, Zou Z, et al. (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

    Article  PubMed  Google Scholar 

  51. Joern F, Gunter H, Thomas J, et al. (2015) Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades. Int J Color Dis 30(6):797–806

    Article  Google Scholar 

  52. Harji DP, Sagar PM, Boyle K, et al. (2013) Surgical resection of recurrent colonic cancer. Br J Surg 100(7):950–958

    Article  CAS  PubMed  Google Scholar 

  53. Yun JA, Yun SH, Park YA et al (2015) Oncologic Outcomes of Single-incision Laparoscopic Surgery Compared With Conventional Laparoscopy for Colon Cancer. Ann Surg. [Epub ahead of print]

  54. Manfredi S, Bouvier AM, Lepage C, et al. (2006) Incidence and patterns of recurrence after resection for cure of colonic cancer in a well Defined population. Br J Surg 93(9):1115–1122

    Article  CAS  PubMed  Google Scholar 

  55. Sjövall A, Granath F, Cedermark B, et al. (2007) Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol 14(2):432–440

    Article  PubMed  Google Scholar 

  56. Colon Cancer Laparoscopic or Open Resection Study Group (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10(1):44–52

    Article  PubMed  Google Scholar 

  57. Elferink MA, Visser O, Wiggers T, et al. (2012) Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol 19(7):2203–2211

    Article  CAS  PubMed  Google Scholar 

  58. Green BL, Marshall HC, Collinson F, et al. (2013) Long-term follow-up of the medical research council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 100(1):75–82

    Article  CAS  PubMed  Google Scholar 

  59. Cortet M, Grimault A, Cheynel N, et al. (2013) Patterns of recurrence of obstructing colon cancers after surgery for cure: a population-based study. Color Dis 15(9):1100–1106

    CAS  Google Scholar 

  60. Kornmann M, Staib L, Wiegel T, et al. (2013) Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer. Clin Colorectal Cancer 12(1):54–61

    Article  CAS  PubMed  Google Scholar 

  61. Krarup PM, Nordholm-Carstensen A, Jorgensen LN, et al. (2014) Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg 259(5):930–938

    Article  PubMed  Google Scholar 

  62. Park JH, Kim MJ, Park SC, et al. (2015) Difference in time to locoregional recurrence between patients with right-sided and left-sided colon cancers. Dis Colon Rectum 58(9):831–837

    Article  PubMed  Google Scholar 

  63. Watanabe T, Itabashi M, Shimada Y, et al. (2015) Japanese society for cancer of the colon and rectum. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 20(2):207–239

    Article  PubMed  PubMed Central  Google Scholar 

  64. van Gestel YR, Thomassen I, Lemmens VE, et al. (2014) Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol 40(8):963–969

    Article  PubMed  Google Scholar 

  65. Kerscher AG, Chua TC, Gasser M, et al. (2013) Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer 108(7):1432–1439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Segelman J, Granath F, Holm T, et al. (2012) Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 99(5):699–705

    Article  CAS  PubMed  Google Scholar 

  67. Chang GJ, Kaiser AM, Mills S, et al. (2012) Standards practice task force of the American society of colon and rectal surgeons. Practice parameters for the management of colon cancer. Dis Colon Rectum 55(8):831–843

    Article  PubMed  Google Scholar 

  68. Bowne WB, Lee B, Wong WD, et al. (2005) Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 48(5):897–909

    Article  PubMed  Google Scholar 

  69. Esquivel J, Elias D, Baratti D, et al. (2008) Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98(4):263–267

    Article  PubMed  Google Scholar 

  70. Chua TC, Morris DL, Esquivel J (2010) Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 17(5):1330–1336

    Article  PubMed  Google Scholar 

  71. Maggiori L, Elias D (2010) Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Eur J Surg Oncol 36(7):599–603

    Article  CAS  PubMed  Google Scholar 

  72. Cashin PH, Dranichnikov F, Mahteme H (2014) Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate. J Surg Oncol 110(2):203–206

    Article  PubMed  Google Scholar 

  73. Goéré D, Malka D, Tzanis D, et al. (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071

  74. Jayne DG, Fook S, Loi C, et al. (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89(12):1545–1550

    Article  CAS  PubMed  Google Scholar 

  75. Hompes D, Tiek J, Wolthuis A, et al. (2012) HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 23(12):3123–3129

    Article  CAS  PubMed  Google Scholar 

  76. Noura S, Ohue M, Shingai T, et al. (2011) Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings. Ann Surg Oncol 18(2):396–404

    Article  PubMed  Google Scholar 

  77. Sloothaak DA, Mirck B, Punt CJ, et al. (2014) Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review. Br J Cancer 111(6):1112–1121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Elias D, Honoré C, Dumont F, et al. (2011) Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of develo** colorectal peritoneal carcinomatosis. Ann Surg 254(2):289–293

    Article  CAS  PubMed  Google Scholar 

  79. Sammartino P, Sibio S, Accarpio F, et al. (2014) Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue. Ann Surg 259(3):e51

    Article  PubMed  Google Scholar 

  80. Klaver CE, Musters GD, Bemelman WA, et al. (2015) Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial. BMC Cancer 15:428

    Article  PubMed  PubMed Central  Google Scholar 

  81. Smith NJ, Bees N, Barbachano Y, et al. (2007) Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. Br J Cancer 96(7):1030–1036

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Dighe S, Blake H, Koh MD, Swift I, et al. (2010) Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg 97(9):1407–1415

    Article  CAS  PubMed  Google Scholar 

  83. Sibileau E, Ridereau-Zins C, Vanel D, et al. (2014) Accuracy of water-enema multidetector computed tomography (WE-MDCT) in colon cancer staging: a prospective study. Abdom Imaging 39(5):941–948

    Article  CAS  PubMed  Google Scholar 

  84. Wiegering A, Kunz M, Hussein M, et al. (2015) Diagnostic value of preoperative CT scan to stratify colon cancer for neoadjuvant therapy. Int J Color Dis 30(8):1067–1073

    Article  Google Scholar 

  85. Stewart CJ, Hillery S, Platell C, et al. (2011) Assessment of serosal invasion and criteria for the classification of pathological (p) T4 staging in colorectal carcinoma: confusions, controversies and criticisms. Cancers (Basel) 3(1):164–181

    Article  Google Scholar 

  86. Gallagher B, Urbanski SJ. The significance of pleural elastica invasion by lung carcinomas. Hum Pathol;21(5):512–517.

  87. Shinto E, Ueno H, Hashiguchi Y et al (2004) The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum;47(4):467–473.

  88. Kojima M, Nakajima K, Ishii G, et al. (2010) Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol 34(9):1351–1360

    Article  PubMed  Google Scholar 

  89. Liang WY, Chang WC, Hsu CY, et al. (2013) Retrospective evaluation of elastic stain in the assessment of serosal invasion of pT3N0 colorectal cancers. Am J Surg Pathol 37(10):1565–1570

    Article  PubMed  Google Scholar 

  90. Yokota M, Kojima M, Nomura S, et al. (2014) Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III. Dis Colon Rectum 57(7):830–838

    Article  PubMed  Google Scholar 

  91. Foxtrot Collaborative Group (2012) Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 13(11):1152–1160

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Sammartino P, Sibio S, Biacchi D, et al. (2012) Prevention of peritoneal metastases from colon cancer in high-risk patients: preliminary results of surgery plus prophylactic HIPEC. Gastroenterol Res Pract 2012:141585

    Article  PubMed  PubMed Central  Google Scholar 

  93. Sammartino P, Sibio S, Biacchi D, et al. (2014) Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. Int J Color Dis 29(9):1081–1089

    Article  CAS  Google Scholar 

  94. Elias D, Lefevre JH, Chevalier J, et al. (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27(5):681–685

    Article  PubMed  Google Scholar 

  95. Ledermann JA, Raja FA, Fotopoulou C, et al. (2013) ESMO Guidelines Working Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi24–vi32

    Article  PubMed  Google Scholar 

  96. Nelson H, Petrelli N, Carlin A, et al. (2001) National cancer institute expert panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93(8):583–596

    Article  CAS  PubMed  Google Scholar 

  97. AJCC Cancer Staging Manual 7th Edition (2010) American joint committee on cancer. Springer, New York

    Google Scholar 

  98. Smeenk RM, van Velthuysen ML, Verwaal VJ, et al. (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34(2):196–201

    Article  CAS  PubMed  Google Scholar 

  99. Amini A, Masoumi-Moghaddam S, Ehteda A, et al. (2014) Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet J Rare Dis 9:71

    Article  PubMed  PubMed Central  Google Scholar 

  100. Jemal A, Siegel R, Ward E, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249

    Article  PubMed  Google Scholar 

  101. Pai RK, Beck AH, Norton JA, et al. (2009) Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol 33(10):1425–1439

    Article  PubMed  Google Scholar 

  102. Shaib WL, Goodman M, Chen Z et al (2015) Incidence and survival of appendiceal mucinous neoplasms: a SEER analysis. Am J Clin Oncol [Epub Ahead of Print]

  103. Wright GP, Mater ME, Carroll JT, et al. (2015) Is there truly an oncologic indication for interval appendectomy? Am J Surg 209(3):442–446

    Article  PubMed  Google Scholar 

  104. Fish R, Selvasekar C, Crichton P, et al. (2014) Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique. Surg Endosc 28(1):341–345

    Article  PubMed  Google Scholar 

  105. Lenz HJ, Stintzing S (2014) So much effort, so little progress? J Natl Cancer Inst 106(10)

Download references

Author information

Authors and Affiliations

  1. Department of Surgery P. Valdoni, University of Rome “Sapienza”, Viale del Policlinico 155, 00186, Rome, Italy

    Paolo Sammartino, Daniele Biacchi, Tommaso Cornali, Maurizio Cardi, Fabio Accarpio, Alessio Impagnatiello, Bianca Maria Sollazzo & Angelo Di Giorgio

Authors
  1. Paolo Sammartino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniele Biacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tommaso Cornali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maurizio Cardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fabio Accarpio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessio Impagnatiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bianca Maria Sollazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Angelo Di Giorgio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Sammartino.

Ethics declarations

Conflict of Interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sammartino, P., Biacchi, D., Cornali, T. et al. Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Indian J Surg Oncol 7, 215–224 (2016). https://doi.org/10.1007/s13193-016-0497-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0497-1

Keywords

Search

Navigation